Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: A4I7Z5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 39 | 43 | PF00656 | 0.582 |
CLV_C14_Caspase3-7 | 67 | 71 | PF00656 | 0.659 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.643 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.644 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.580 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.644 |
CLV_PCSK_PC1ET2_1 | 150 | 152 | PF00082 | 0.580 |
CLV_PCSK_SKI1_1 | 13 | 17 | PF00082 | 0.679 |
DEG_SPOP_SBC_1 | 80 | 84 | PF00917 | 0.644 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.657 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.664 |
DOC_USP7_UBL2_3 | 146 | 150 | PF12436 | 0.618 |
LIG_14-3-3_CanoR_1 | 96 | 106 | PF00244 | 0.645 |
LIG_APCC_ABBA_1 | 34 | 39 | PF00400 | 0.544 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.648 |
LIG_BRCT_BRCA1_1 | 106 | 110 | PF00533 | 0.610 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.624 |
LIG_FHA_2 | 52 | 58 | PF00498 | 0.741 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.698 |
LIG_LIR_Nem_3 | 107 | 113 | PF02991 | 0.608 |
LIG_NRP_CendR_1 | 150 | 153 | PF00754 | 0.696 |
LIG_PCNA_PIPBox_1 | 121 | 130 | PF02747 | 0.482 |
LIG_Pex14_1 | 28 | 32 | PF04695 | 0.557 |
LIG_PTB_Apo_2 | 126 | 133 | PF02174 | 0.488 |
LIG_SH2_NCK_1 | 20 | 24 | PF00017 | 0.634 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.557 |
LIG_TRAF2_1 | 50 | 53 | PF00917 | 0.605 |
LIG_WRC_WIRS_1 | 124 | 129 | PF05994 | 0.534 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.693 |
MOD_CK1_1 | 109 | 115 | PF00069 | 0.477 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.587 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.627 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.599 |
MOD_CK2_1 | 61 | 67 | PF00069 | 0.679 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.656 |
MOD_Cter_Amidation | 147 | 150 | PF01082 | 0.560 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.592 |
MOD_GlcNHglycan | 44 | 47 | PF01048 | 0.604 |
MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.635 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.548 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.601 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.645 |
MOD_GSK3_1 | 66 | 73 | PF00069 | 0.661 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.576 |
MOD_N-GLC_1 | 141 | 146 | PF02516 | 0.449 |
MOD_N-GLC_1 | 42 | 47 | PF02516 | 0.534 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.522 |
MOD_PIKK_1 | 51 | 57 | PF00454 | 0.649 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.695 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.666 |
MOD_Plk_1 | 42 | 48 | PF00069 | 0.543 |
MOD_Plk_1 | 57 | 63 | PF00069 | 0.669 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.553 |
MOD_Plk_4 | 57 | 63 | PF00069 | 0.634 |
MOD_SUMO_for_1 | 101 | 104 | PF00179 | 0.569 |
TRG_DiLeu_BaEn_2 | 132 | 138 | PF01217 | 0.497 |
TRG_ER_diArg_1 | 5 | 8 | PF00400 | 0.693 |
TRG_NLS_MonoExtC_3 | 148 | 153 | PF00514 | 0.694 |
TRG_NLS_MonoExtN_4 | 146 | 153 | PF00514 | 0.680 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P974 | Leptomonas seymouri | 51% | 100% |
A0A1X0NT35 | Trypanosomatidae | 32% | 90% |
A0A3S7X5K4 | Leishmania donovani | 99% | 100% |
A0A422NH51 | Trypanosoma rangeli | 29% | 95% |
A4HKG8 | Leishmania braziliensis | 74% | 100% |
D0AA62 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 97% |
E9B2V7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q599 | Leishmania major | 93% | 100% |